A dual orexin receptor antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Vornorexant

Item No. 46563

Technical Information
Formal Name
[(2S)-2-[[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]methyl]dihydro-2H-1,3-oxazin-3(4H)-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-methanone
CAS Number
1517965-94-4
Synonyms
  • ORN-0829
  • TS-142
Molecular Formula
C23H22FN7O2
Formula Weight
Purity
≥98%
A solid
SMILES
O=C(N1[C@@H](OCCC1)CN2N=C(C3=CC=C(C=N3)F)C=C2)C4=C(N5N=CC=N5)C=CC(C)=C4
InChi Code
InChI=1S/C23H22FN7O2/c1-16-3-6-21(31-26-8-9-27-31)18(13-16)23(32)30-10-2-12-33-22(30)15-29-11-7-20(28-29)19-5-4-17(24)14-25-19/h3-9,11,13-14,22H,2,10,12,15H2,1H3/t22-/m0/s1
InChi Key
AEZZJXJIJFSUEM-QFIPXVFZSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Vornorexant is a dual orexin receptor antagonist (DORA).1 It inhibits [Ala6,12]-orexin A-induced calcium mobilization in CHO-K1 cells expressing recombinant human orexin receptor 1 (OX1R) or OX2R (IC50s = 1.05 and 1.27 nM, respectively). Vornorexant (1, 3, and 10 mg/kg, p.o.) decreases sleep latency and increases total sleep in rats. Formulations containing vornorexant have been used in the treatment of insomnia.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Futamura, A., Suzuki, R., Tamura, Y., et al. Discovery of ORN0829, a potent dual orexin ½ receptor antagonist for the treatment of insomnia. Bioorg. Med. Chem. 28(12), 115489 (2020).